The Bethesda System for Reporting Cervical Cytology

Definitions, Criteria, and Explanatory Notes
It has been over 10 years since The Bethesda System (TBS) has been updated and revised.  The American Society of Cytopathology (ASC) has taken the lead in developing the third Bethesda Atlas which will (1) expand the breadth of images (particularly for liquid based preparations); (2) address several clinicocytopathologic issues that have arisen in clinical practice; and (3) incorporate the concept of risk-based management which served as the basis for the most recent American Society for Colposcopy and Cervical Pathology management guidelines.  These updates, while important, will not result in major changes to the terminology and do not warrant a full Bethesda Workshop. Under the leadership of Drs. David Wilbur and Ritu Nayar, each atlas section will be updated with new references and images. 

1)  Specimen Adequacy
George G. Birdsong and Diane D. Davey

2)  Non-Neoplastic Findings
Terence J. Colgan, David C. Wilbur and Ritu Nayar

3)  Endometrial Cells: The How and When of Reporting                                         
Ann T. Moriarty, Edmund S. Cibas Alan Waxman, and David Chelmow

4)  Atypical Squamous Cells                                                                                         
Fadi W. Abdul-Karim, Celeste N. Powers, and Mary K. Sidawy

5)  Epithelial Abnormalities: Squamous
Michael R. Henry, Donna K. Russell, and Ritu Nayar

6)  Epithelial Abnormalities: Glandular
Jamie L. Covell, David C. Wilbur, David C. Chhieng, and Dina R. Mody

7)  Other Malignant Neoplasms                                                                                   
Sana O. Tabbara and Walid E. Khalbuss

8)  Anal-Rectal Cytology                                                                                               
Teresa M. Darragh, and Joel M. Palefesky

9)  Ancillary Testing       
Mark H. Stoler, and David C. Wilbur

10)  Computer-Assisted Interpretation of Cervical Cytology
David C. Wilbur

11)  Educational Notes and Suggestions Appended to Cytology Reports                  
Teresa M. Darragh  and Ritu Nayar  

12)  Risk Assessment and Management
David P. Chelmow, Teresa M. Darragh, Mark Schiffman, Alan G. Waxman, and Nicolas Wentzensen